Hearing Loss, Conductive: Clinical Trials

1 trial for Hearing Loss, Conductive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Hearing Loss, Conductive: new trials by email Literature Review of Hearing Loss, Conductive trials Research Report on Hearing Loss, Conductive

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Omega-3-Based Nutraceutical Supplementation as Adjunctive Therapy in Adults With Otitis Media With Effusion: A Multicenter, Double-Blind, Randomized Placebo-Controlled Trial
Omega-3-based nutraceutical combination (Otoair Flogo), Bilastine 20 mg, Placebo Tablet or Capsule - Otits Media With Effusion
Phase 4CompletedIsola Tiberina - Gemelli Isola Hospital, Rome, Italy5012025-10-012026-07-23

Narrower conditions

Hearing Loss (1)  ·  Otitis Media with Effusion (1)

Broader conditions

Ear Diseases (1)  ·  Hearing Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Otitis (1)  ·  Otitis Media (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sensation Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Adrenal Cortex Hormones (1)  ·  Capsules (1)  ·  Fatty Acids, Omega-3 (1)  ·  Magnesium (1)  ·  Mometasone Furoate (1)  ·  Vitamin B 6 (1)  ·  bilastine (1)  ·  deflazacort (1)

Sponsors

Isola Tiberina - Gemelli Isola Hospital, Rome, Italy (1)

Countries

Italy (1)